Statistics

Total Visits

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial50

Select a period of time:

Number of views in the range

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial28

Views

Views
October 20242
November 20241
December 20241
January 20252
February 20257
March 202515
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States12
Germany1
 

Top cities views

Views